Valuation: Danaher Corporation

Capitalization 147B 125B 114B 109B 202B 13,373B 209B 1,327B 526B 6,452B 553B 542B 22,759B P/E ratio 2025
45.3x
P/E ratio 2026 * 32.6x
Enterprise value 161B 136B 124B 119B 220B 14,589B 228B 1,447B 573B 7,038B 603B 591B 24,829B EV / Sales 2025
7.14x
EV / Sales 2026 * 6.14x
Free-Float
72.69%
Yield 2025 *
0.6%
Yield 2026 * 0.63%
1 day+1.07%
1 week-5.19%
Current month-4.72%
1 month-11.62%
3 months-7.52%
6 months-0.22%
Current year-8.89%
1 week 201
Extreme 201
218.75
1 month 201
Extreme 201
242.8
Current year 201
Extreme 201
242.8
1 year 171
Extreme 171
242.8
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO 54 01/01/2019
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1983
Director/Board Member 69 01/01/1983
Change 5d. change 1-year change 3-years change Capi.($)
+1.07%-5.19%+1.97%-18.62% 146B
+2.39%-2.58%-1.82%-8.24% 188B
+1.50%+0.94%-16.66%+109.60% 175B
-0.01%+3.82%-27.59%+63.90% 113B
+1.64%+3.49%-27.37%-17.53% 53.88B
+0.68%-0.44%+4.37%+0.60% 45.52B
+1.21%-0.27%+12.29%+19.79% 37.27B
+1.64%+4.73%-10.49%+13.37% 37.19B
+2.48%-1.52%-6.11%-14.38% 35.04B
-1.19%-1.82%-27.55%-41.76% 32.53B
Average +1.14%-0.58%-9.90%+10.67% 86.41B
Weighted average by Cap. +1.32%-1.57%-9.74%+23.86%

Financials

2025 2026 *
Net sales 24.53B 20.76B 18.94B 18.11B 33.54B 2,225B 34.7B 221B 87.44B 1,073B 92B 90.1B 3,787B 25.64B 21.7B 19.8B 18.93B 35.06B 2,326B 36.28B 231B 91.41B 1,122B 96.17B 94.19B 3,958B
Net income 3.7B 3.13B 2.86B 2.73B 5.06B 336B 5.24B 33.32B 13.2B 162B 13.89B 13.6B 572B 4.61B 3.9B 3.56B 3.4B 6.3B 418B 6.52B 41.49B 16.44B 202B 17.29B 16.94B 712B
Net Debt 13.41B 11.35B 10.35B 9.9B 18.34B 1,216B 18.97B 121B 47.8B 587B 50.3B 49.26B 2,070B 10.12B 8.57B 7.81B 7.47B 13.84B 918B 14.32B 91.07B 36.08B 443B 37.96B 37.17B 1,562B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
60,000
Date Price Change Volume
18/02/26 208.56 $ +1.07% 4,646,882
17/02/26 206.36 $ -2.93% 8,709,352
13/02/26 212.58 $ -1.10% 5,286,473
12/02/26 214.94 $ -2.29% 5,167,080
11/02/26 219.98 $ +0.10% 4,539,142
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
208.56USD
Average target price
264.91USD
Spread / Average Target
+27.02%

Quarterly revenue - Rate of surprise